Malaria
A first shipment of 331,200 doses of RTS,S vaccine landed in Cameroon Tuesday (Nov. 21).
The World Health Organization, the UN children's agency UNICEF and the Gavi vaccine alliance said in a joint statement Wednesday (Nov.22) that the delivery "[signaled] that scale-up of vaccination against malaria across the highest-risk areas on the African continent [would] begin shortly".
RTS,S— is the first malaria vaccine recommended by the WHO.
The jab acts against plasmodium falciparum—the deadliest malaria parasite globally and the most prevalent in Africa.
It is administered in a four-dose schedule which begins at around the age of five months old.
Several African countries are finalizing preparations for malaria vaccine introduction into routine immunization programs, with the first doses set to be administered in January-March 2024.
A further 1.7 million doses are set for delivery to Burkina Faso, Liberia, Niger and Sierra Leone in the coming weeks.
The shipments signal that malaria vaccination is moving out of its pilot phase
Since 2019, more than two million children have been jabbed in Ghana, Kenya and Malawi in a pilot phase, resulting in substantial reductions in severe malaria illness and hospitalizations.
Africa accounted for approximately 95 percent of global malaria cases and 96 percent of related deaths from the mosquito-borne disease in 2021.
Global malaria deaths dipped slightly to 619,000 in 2021—of which 77 percent were children aged under five. Meanwhile, global malaria cases rose slightly to 247 million.
02:03
Sudanese doctors offer free medical services to displaced people
02:31
Cholera outbreak: Medical experts, government move to curb spread
01:54
Paris 2024 Olympics: concerns linger over the Seine's water quality
01:17
Ivory Coast rolls out malaria vaccine drive targeting children
01:20
Nearly 160 health facilities in Syria at risk
01:07
One-third of adults worldwide at risk of disease from not doing enough physical activity